Reviva Pharmaceuticals Holdings, Inc.

As of June 4, 2025, the market trend is mildly bearish, influenced by daily moving averages and Bollinger Bands, despite some mixed signals from weekly and monthly indicators suggesting caution.

Reviva Pharmaceuticals Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net loss of $6 million and a market cap of $33.65 million. Key metrics include a debt-to-equity ratio of 1.14 and a return on equity of 655.62%.

As of Jun 18, Reviva Pharmaceuticals Holdings, Inc. has a market capitalization of 33.65 million and reported net sales of 0.00 million with a net profit of -28.92 million over the last four quarters. Shareholder's funds are 0.81 million, and total assets amount to 15.50 million.